Skip to content

Furosemide EP Impurity D

Furosemide EP Impurity D

Product Description
CAT No.
ALN-F032005
CAS No.
5046-19-5
Mol. F.
C17H17N3O6S
Mol. Wt.
391.4
Stock
In Stock
RFQ
Chemical Name : 2,4-Bis[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid
Smiles : O=C(O)C1=CC(S(=O)(N)=O)=C(NCC2=CC=CO2)C=C1NCC3=CC=CO3
Inchi : InChI=1S/C7H7ClN2O4S/c8-4-2-5(9)3(7(11)12)1-6(4)15(10,13)14/h1-2H,9H2,(H,11,12)(H2,10,13,14)

A New Way of Stabilization of Furosemide upon Cryogenic Grinding by Using Acylated Saccharides Matrices. The Role of Hydrogen Bonds in Decomposition Mechanism

E. Kaminska,*,u2020 K. Adrjanowicz,u2021,u00a7 K. Kaminski,u00a7,u2225 P. Wlodarczyk,u22a5 L. Hawelek,u00a7,u22a5 K. Kolodziejczyk,u00a7 M. Tarnacka,u00a7 D. Zakowiecki,# I. Kaczmarczyk-Sedlak,u2020 J. Pilch,u2207 and M. PaluchnMol. Pharmaceutics 2013, 10, 5, 1824u20131835

Effect of Cryogrinding on Chemical Stability of the Sparingly Water-Soluble Drug Furosemide

,† K. Adrjanowicz,‡,§ K. Kaminski,§,∥ P. Wlodarczyk,⊥ L. Hawelek,§,⊥ K. Kolodziejczyk,§ M. Tarnacka,§ D. Zakowiecki,# I. Kaczmarczyk-Sedlak,† J. Pilch,∇ and M. Paluch – Mol. Pharmaceutics 2013, 10, 5, 1824–1835

Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide

Karolina Adrjanowicz, Kamil Kaminski, Katarzyna Grzybowska, Lukasz Hawelek, Marian Paluch, Irena Gruszka, Daniel Zakowiecki, Wieslaw Sawicki, Przemyslaw Lepek, Wojciech Kamysz & Lukasz Guzik – Pharmaceutical Research volume 28, pages3220–3236(2011)

Request For Quotation

Related Products